Finansal Hizmetler

Total Market Cap 5,611.9B
P/E (Weighted)Price to Earnings ratio. 77.51 Medyan: 100.00
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 5.00
P/E (Arithmetic)Simple average P/E. 88.06
Avg Lothien ScoreFinancial health score (0-100). 55
Avg DamodaranDamodaran scoring model. 35
Avg PotentialExpected upside potential %. +1.9%
Avg Dalio ScoreDalio debt cycle score. 67
Distributions
Lothien Distribution
0–25
0
25–40
4
40–55
43
55–70
25
70–100
8
Damodaran Distribution
0–25
17
25–40
40
40–55
19
55–70
4
70–100
0
Upside Potential
-100% – -20%
21
-20% – +0%
23
+0% – +20%
21
+20% – +50%
7
+50%+
8

Data date 2026-10-16 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-16
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
LUND_B
571.00 12.6B 7.66 0.99 16.81 — — 87 69 1,554.41 +129.2% 81 2.00
INDU_A
515.00 222.4B 34.02 11.22 0.90 — — 84 51 881.04 +53.3% 97 0.32
INDU_C
513.40 221.7B 33.60 11.08 0.90 — — 84 51 884.52 +54.2% 96 0.31
INVE_A
409.60 1,254.8B 41.10 13.07 1.16 — — 80 47 597.21 +33.0% 84 0.12
SAGA_D
30.75 15.2B 28.67 3.80 31.81 — — 80 39 64.44 +78.9% 67 0.94
AKERO
1,260.00 93.6B 2.49 14.92 3.31 — — 79 54 2,362.44 +65.6% 83 0.68
ORES
145.80 6.5B 54.50 13.21 2.41 — — 78 50 208.86 +32.4% 98 0.02
VOLO
25.70 2.0B 4.13 17.45 39.93 — — 75 52 41.07 +44.9% 72 1.33
ENITY
75.50 3.8B 81.37 6.96 0.71 — — 68 33 109.43 +32.4% 95 1.28
TRAC_B
255.00 3.8B 79.91 9.58 2.62 — — 67 34 349.07 +26.6% 65 0.00
BURE
293.60 21.7B 34.93 9.60 60.85 — — 66 40 323.70 +7.4% 62 0.00
DNBO
306.90 439.7B 100.00 17.07 1.44 — — 66 39 353.11 +10.8% 95 3.51
INTEA_D
28.90 8.4B 59.17 7.32 55.75 — — 66 34 31.31 +6.0% 63 1.12
NOBA
89.10 44.5B 100.00 18.08 1.44 — — 65 38 101.11 +9.7% 96 1.09
SHB_B
241.40 478.0B 100.00 29.16 2.64 — — 65 36 238.96 -0.7% 93 9.68
AVARDA
221.00 14.3B 100.00 48.02 1.71 — — 64 43 216.33 -1.5% 100 0.12
EAST
42.90 4.2B 100.00 8.94 22.21 — — 64 27 51.48 +14.4% 91 1.06
NDA_SE
190.05 645.0B 100.00 20.71 17.43 — — 64 39 207.65 +6.7% 95 7.06
NORION
60.70 11.5B 100.00 12.95 0.74 — — 63 36 72.39 +13.9% 96 0.29
SAVE
339.60 84.4B 100.00 118.19 7.21 — — 63 44 322.02 -3.7% 100 116.12
SEB_C
225.50 439.6B 100.00 21.82 1.60 — — 63 38 240.75 +4.9% 95 4.23
AZA
365.70 57.8B 100.00 81.57 2.97 — — 62 44 351.92 -2.7% 100 0.04
MORROW
15.00 4.7B 100.00 18.24 0.65 — — 62 32 15.94 +4.5% 96 0.45
SFAST
10.48 3.5B 76.74 6.67 42.92 — — 61 32 12.49 +12.9% 59 1.40
CORE_B
2.00 2.5B — 1.82 29.33 — — 60 60 5.64 +102.0% 28 1.97
DIOS
56.85 7.9B 81.26 7.32 60.97 — — 59 29 54.81 -2.4% 54 1.45
NIVI_B
34.95 3.2B 88.76 6.20 70.41 — — 59 29 35.34 +0.8% 64 1.28
HEBA_B
23.45 3.6B 93.29 6.36 68.16 — — 58 27 22.56 -2.7% 62 1.11
RATO_A
37.00 12.1B — 9.44 37.56 — — 57 43 46.07 +15.7% 68 0.54
RATO_B
37.20 12.2B — 9.51 37.85 — — 57 43 45.97 +15.1% 68 0.54
AGROUP
35.20 2.2B 100.00 5.54 79.33 — — 56 25 33.05 -4.4% 69 0.37
CORE_A
3.20 4.0B — 2.93 37.91 — — 56 58 8.06 +85.0% 28 1.97
JOMA
54.80 4.1B 84.05 6.95 92.80 — — 56 28 48.46 -7.8% 59 1.21
NEOBO
16.82 2.3B 100.00 4.05 71.56 — — 55 51 29.07 +40.8% 38 1.09
PNDX_B
154.80 30.1B 100.00 9.84 59.10 — — 55 32 131.58 -10.8% 63 1.58
ABGO
7.15 3.7B 93.44 39.24 61.84 — — 54 46 5.01 -21.5% 70 0.11
BALD_B
44.65 49.2B 90.73 6.05 77.92 — — 54 29 41.91 -4.4% 66 1.69
PRISMA
26.20 4.3B 100.00 9.42 79.87 — — 54 27 19.85 -17.4% 87 1.13
STOR_B
11.27 17.6B 100.00 9.36 51.80 — — 54 28 9.22 -13.1% 81 0.53
INTEA_B
62.90 13.1B 92.52 11.45 83.05 — — 53 31 45.41 -20.9% 71 1.12
NP3
227.50 14.0B 99.38 14.07 73.53 — — 53 34 162.93 -20.4% 76 1.42
SBB_B
2.29 4.1B — 2.32 29.35 — — 53 59 6.46 +101.8% 30 2.00
WALL_B
35.24 22.4B 81.82 7.68 95.83 — — 53 28 26.70 -16.2% 59 1.07
EMIL_B
43.00 4.9B 95.49 9.82 84.88 — — 52 30 32.85 -17.0% 66 1.33
BRIN_B
11.25 2.6B 100.00 3.99 66.58 — — 51 23 11.75 +3.0% 35 1.53
CATE
342.60 22.7B 100.00 9.34 91.78 — — 51 28 250.02 -19.5% 65 0.93
WIHL
70.15 21.6B 100.00 10.04 70.58 — — 51 31 54.11 -16.5% 70 1.48
HUFV_A
107.50 20.0B 100.00 8.01 141.59 — — 50 23 66.63 -27.4% 67 0.46
LATO_B
206.00 121.9B 100.00 31.35 158.10 — — 50 35 81.28 -45.4% 89 0.42
STEF_B
151.00 4.6B 100.00 7.95 76.25 — — 50 25 118.23 -14.5% 54 1.63
SVEAF
30.90 6.1B 100.00 4.57 84.92 — — 50 24 28.35 -5.5% 45 0.91
TRIAN_B
15.55 2.9B 100.00 6.06 65.08 — — 50 27 14.78 -3.3% 54 1.42
SPLTN
172.80 4.9B — 7.28 — — — 49 30 227.14 +13.5% 41 0.00
CAST
125.85 57.0B 100.00 8.49 133.39 — — 48 23 72.02 -30.8% 64 0.75
KFAST_B
10.00 2.2B 100.00 4.94 43.08 — — 48 25 11.02 +6.9% 32 2.80
LINC
68.10 3.9B — 9.86 133.07 — — 48 22 43.40 -23.2% 83 0.00
ROKO_B
1,924.00 28.1B 100.00 52.02 257.75 — — 48 28 505.08 -55.3% 82 0.49
SAGA_B
163.10 80.7B 100.00 20.08 141.27 — — 48 29 74.40 -40.8% 79 0.94
ALTRA
70.05 12.3B 100.00 8.44 72.34 — — 47 25 50.68 -18.5% 48 1.41
CIBUS
127.00 10.4B 100.00 10.27 80.50 — — 47 29 90.71 -21.4% 61 1.65
FLAT_B
7.69 3.8B — 7.80 — — — 47 30 9.66 +12.3% 72 0.09
STBO
190.60 79.8B 100.00 26.52 — — — 47 37 70.85 -43.4% 88 1.96
BESQAB
23.00 2.4B 100.00 8.91 174.66 — — 46 22 13.41 -30.0% 66 0.84
BONAV_A
8.45 2.7B 100.00 4.52 104.83 — — 46 22 9.24 +5.6% 53 0.78
BONAV_B
8.34 2.7B 100.00 4.46 103.66 — — 46 22 9.23 +6.3% 53 0.78
EQT
298.10 372.7B 100.00 49.60 268.47 — — 46 23 77.36 -55.5% 97 0.35
PLAZ_B
61.40 7.2B 100.00 6.23 73.84 — — 46 25 53.20 -9.0% 44 1.16
SAGA_A
163.00 80.6B 100.00 20.12 141.58 — — 46 29 74.20 -40.9% 79 0.94
IDUN_B
321.00 3.7B 100.00 66.76 103.98 — — 45 27 119.88 -47.0% 91 1.79
HEM
74.05 6.4B 100.00 84.83 106.94 — — 44 43 30.97 -43.6% 90 1.02
SBB_D
6.82 12.1B — 6.91 61.24 — — 44 51 9.02 +18.0% 35 2.00
SVOL_A
99.50 10.2B 70.51 18.96 — — — 43 27 42.65 -36.6% 28 0.00
ATRLJ_B
21.30 13.0B 100.00 5.23 119.02 — — 42 22 15.98 -16.7% 51 1.04
KINV_A
78.00 22.0B — 8.35 — — — 41 51 87.31 +5.7% 18 0.07
SVOL_B
61.00 6.2B 100.00 12.26 — — — 41 49 30.46 -25.5% 32 0.00
VNV
18.28 2.3B — 5.78 — — — 41 54 29.59 +29.7% 9 0.06
FPAR_A
37.45 7.1B 100.00 5.52 106.16 — — 39 22 27.88 -17.1% 39 1.24
FPAR_D
70.60 13.4B 100.00 10.41 183.06 — — 37 19 32.66 -38.7% 50 1.24
JM
120.00 7.7B — 11.09 419.45 — — 33 27 67.35 -22.4% 46 1.80
CORE_D
195.40 242.6B — 179.00 1,402.28 — — 28 0 48.85 -38.2% 28 1.97
KLARA_B
13.60 — — — — — — — — — — — —

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.